☆ 4.2 Article

PharmGKB summary: very important pharmacogene information for the epidermal growth factor receptor

PHARMACOGENETICS AND GENOMICS (2013)

Get Full Text
Add to Collection

Journal

PHARMACOGENETICS AND GENOMICS
Volume 23, Issue 11, Pages 636-642

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FPC.0b013e3283655091

Keywords

epidermal growth factor receptor; erlotinib; gefitinib; pharmacogenomics; tyrosine kinase inhibitor

Categories

Biotechnology & Applied Microbiology Genetics & Heredity Pharmacology & Pharmacy

Funding

  1. National Institutes of Health/National Institute of General Medical Sciences [R24 GM61374]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.